GT
SWAV

Glenmede Trust’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Glenmede Trust’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,602
Closed -$564K – 1381
2023
Q2 		$564K Hold
2,602
– – ﹤0.01% 801
2023
Q1 		$564K Sell
2,602
-123
-5% -$24K ﹤0.01% 804
2022
Q4 		$560K Buy
2,725
+853
+46% +$216K ﹤0.01% 810
2022
Q3 		$519K Sell
1,872
-3,366
-64% -$856K ﹤0.01% 811
2022
Q2 		$1M Buy
5,238
+2,139
+69% +$378K 0.01% 678
2022
Q1 		$642K Buy
+3,099
New +$511K ﹤0.01% 829

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Glenmede Trust's SWAV Position: Q3 2023 in Review

Glenmede Trust sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 2,602 shares — an estimated $564K sold.

Glenmede Trust first reported a position in SWAV in Q1 2022 and held it in 6 quarters. The position peaked at $1M in Q2 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Glenmede Trust reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Glenmede Trust sold 2,602 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $564K.
  • Glenmede Trust first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Glenmede Trust's Shockwave Medical, Inc. Common Stock position peaked at $1M in Q2 2022.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.